Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine-Related Disorders | 4 | 2024 | 102 | 1.570 |
Why?
|
| Self Administration | 3 | 2024 | 69 | 1.010 |
Why?
|
| Neuronal Plasticity | 2 | 2019 | 126 | 0.930 |
Why?
|
| Cocaine | 3 | 2024 | 251 | 0.920 |
Why?
|
| Action Potentials | 2 | 2019 | 246 | 0.870 |
Why?
|
| Recurrence | 2 | 2024 | 152 | 0.870 |
Why?
|
| Extinction, Psychological | 3 | 2019 | 104 | 0.830 |
Why?
|
| Cues | 1 | 2024 | 81 | 0.820 |
Why?
|
| Neurons | 3 | 2019 | 1263 | 0.820 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 3 | 2017 | 33 | 0.780 |
Why?
|
| Limbic System | 2 | 2013 | 31 | 0.750 |
Why?
|
| Sex Characteristics | 1 | 2024 | 258 | 0.750 |
Why?
|
| Prefrontal Cortex | 2 | 2019 | 164 | 0.670 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2017 | 92 | 0.630 |
Why?
|
| Association Learning | 1 | 2019 | 35 | 0.620 |
Why?
|
| Stress, Psychological | 1 | 2024 | 661 | 0.550 |
Why?
|
| Riluzole | 1 | 2017 | 6 | 0.540 |
Why?
|
| Fear | 3 | 2019 | 272 | 0.510 |
Why?
|
| Dopamine Uptake Inhibitors | 3 | 2024 | 83 | 0.460 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2013 | 26 | 0.390 |
Why?
|
| Receptors, Muscarinic | 1 | 2012 | 16 | 0.370 |
Why?
|
| Synapses | 1 | 2013 | 185 | 0.360 |
Why?
|
| Rats | 5 | 2024 | 3735 | 0.270 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2017 | 1766 | 0.270 |
Why?
|
| Animals | 9 | 2024 | 16992 | 0.250 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2024 | 126 | 0.200 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1070 | 0.180 |
Why?
|
| Male | 7 | 2024 | 23409 | 0.160 |
Why?
|
| Brain | 2 | 2017 | 1472 | 0.150 |
Why?
|
| Conditioning, Classical | 1 | 2019 | 67 | 0.150 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2019 | 7 | 0.150 |
Why?
|
| Neuropeptide Y | 1 | 2019 | 25 | 0.150 |
Why?
|
| Reward | 1 | 2019 | 112 | 0.140 |
Why?
|
| Dietary Sucrose | 1 | 2017 | 17 | 0.140 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 36 | 0.140 |
Why?
|
| Amino Acid Transport Systems, Acidic | 1 | 2017 | 2 | 0.130 |
Why?
|
| Pyramidal Cells | 1 | 2017 | 65 | 0.130 |
Why?
|
| Ceftriaxone | 1 | 2017 | 7 | 0.130 |
Why?
|
| Membrane Potentials | 1 | 2017 | 222 | 0.130 |
Why?
|
| Receptors, AMPA | 1 | 2017 | 58 | 0.130 |
Why?
|
| Nucleus Accumbens | 1 | 2017 | 100 | 0.120 |
Why?
|
| Astrocytes | 1 | 2017 | 244 | 0.120 |
Why?
|
| Motor Activity | 1 | 2017 | 437 | 0.110 |
Why?
|
| Feeding Behavior | 1 | 2017 | 469 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2017 | 392 | 0.100 |
Why?
|
| Cholinergic Agents | 1 | 2012 | 8 | 0.090 |
Why?
|
| Organ Culture Techniques | 1 | 2012 | 101 | 0.090 |
Why?
|
| Female | 2 | 2024 | 24698 | 0.060 |
Why?
|
| Neural Pathways | 1 | 2019 | 138 | 0.030 |
Why?
|
| Humans | 2 | 2019 | 43102 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2017 | 75 | 0.030 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2017 | 5 | 0.030 |
Why?
|
| Conditioning, Operant | 1 | 2017 | 90 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 536 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2017 | 403 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 1869 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 1596 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2017 | 1271 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 1604 | 0.020 |
Why?
|
| Mice | 1 | 2019 | 6644 | 0.020 |
Why?
|
Sepulveda Orengo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(60)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_